2022
-
Shaimardanova A.A, Chulpanova D.S, Solovyeva V.V, Functionality of a bicistronic construction containing HEXA and HEXB genes encoding ?-hexosaminidase A for cell-mediated therapy of GM2 gangliosidoses//Neural Regeneration Research. - 2022. - Vol.17, Is.1. - P.122-129.
-
Shaimardanova A.A, Chulpanova D.S, Mullagulova A.I, Gene and Cell Therapy for Epilepsy: A Mini Review//Frontiers in Molecular Neuroscience. - 2022. - Vol.15, Is.. - Art. №868531.
-
Issa S.S, Shaimardanova A.A, Valiullin V.V, Mesenchymal Stem Cell-Based Therapy for Lysosomal Storage Diseases and Other Neurodegenerative Disorders//Frontiers in Pharmacology. - 2022. - Vol.13, Is.. - Art. №859516.
-
Chulpanova D.S, Shaimardanova A.A, Ponomarev A.S, Current Strategies for the Gene Therapy of Autosomal Recessive Congenital Ichthyosis and Other Types of Inherited Ichthyosis//International Journal of Molecular Sciences. - 2022. - Vol.23, Is.5. - Art. №2506.
2021
2020
-
Shaimardanova A, Solovyeva V, Chulpanova D, Extracellular vesicles in the diagnosis and treatment of central nervous system diseases//Neural Regeneration Research. - 2020. - Vol.15, Is.4. - P.586-596.
-
Shaimardanova A.A, Chulpanova D.S, Solovyeva V.V, New therapeutic strategies for the treatment of metachromatic leukodystrophy//Genes and Cells. - 2020. - Vol.15, Is.2. - P.41-50.
-
Shaimardanova A.A, Chulpanova D.S, Solovyeva V.V, Metachromatic Leukodystrophy: Diagnosis, Modeling, and Treatment Approaches//Frontiers in Medicine. - 2020. - Vol.7, Is.. - Art. № 576221.
-
Solovyeva V.V, Shaimardanova A.A, Chulpanova D.S, Tay-Sachs disease: Diagnostic, modeling and treatment approaches//Genes and Cells. - 2020. - Vol.15, Is.1. - P.17-22.
2019
-
Shaimardanova A.A, Kitaeva K.V, Abdrakhmanova I.I, Production and application of multicistronic constructs for various human disease therapies//Pharmaceutics. - 2019. - Vol.11, Is.11. - Art. № 580.
- Shaimardanova A. A., Chulpanova D. S., Solovyeva V. V., Generation and functional analysis of plasmid DNA encoding beta-hexosaminidase gene for Tay-Sachs disease therapy//HUMAN GENE THERAPY. - 2019. - Vol.30, Is.11. - P.A155-A156.
- Starostina I. G., Shaimardanova A. A., Agliullina D. R., Gene modification of HEK293A cells using CRISPR-Cas9 SAM technology for the transcriptional activation of dysferlin gene//HUMAN GENE THERAPY. - 2019. - Vol.30, Is.11. - P.A190-A190.
2018
-
Solovyeva V.V. New Approaches to Tay-Sachs Disease Therapy / V.V. Solovyeva, A.A. Shaimardanova, D.S. Chulpanova, K.V. Kitaeva, L. Chakrabarti, A.A. Rizvanov // Front. Physiol. – 2018.
-
Solovyeva V.V, Shaimardanova A.A, Chulpanova D.S, New approaches to Tay-Sachs disease therapy//Frontiers in Physiology. - 2018. - Vol.9, Is.NOV. - Art. № 1663.
- Shaimardanova A. A., Starostina I. G., Solovyeva V. V., Transcriptional activation of mutant dysferlin gene expression in human skin fibroblasts using CRISPR/Cas9 SAM technology//HUMAN GENE THERAPY. - 2018. - Vol.29, Is.12. - P.A142-A142.
- Starostina I. G., Shaimardanova A. A., Solovyeva V. V., Biosynthesis of DYSF protein in Bla/J dysferlin-deficient mice after administration of recombinant adenovirus encoding dysferlin cDNA//HUMAN GENE THERAPY. - 2018. - Vol.29, Is.12. - P.A138-A138.
- Chulpanova D. S., Shaimardanova A. A., Solovyeva V. V., MyoD-directed reprogramming of fibroblasts with DYSF gene mutation for human dysferlinopathy modeling//HUMAN GENE THERAPY. - 2018. - Vol.29, Is.12. - P.A98-A98.
- Starostina I. G., Solovyeva V. V., Shaimardanova A. A., Analysis of ectopic dysferlin expression effect on the proliferative activity of HEK293A cells after electroporation//HUMAN GENE THERAPY. - 2018. - Vol.29, Is.12. - P.A99-A99.
2017
| Work address: | 9 Parizhskoy Kommuny Str., Kazan, Academic and Research Centre of the Institute of Fundamental Medicine and Biology |
| Office number: | 322 |
| E-mail: | AlisAShajmardanova@kpfu.ru |
| VK: | https://vk.com/shaimardanovaa |
| Google scholar: | https://scholar.google.ru/citations?user=sS9CGJ8AAAAJ&hl=ru |
| Instagram: | https://www.instagram.com/alice_shaimardanova/ |
| Experience: |
| Scientific and pedagogical experience: |
| General experience: |
| Experience in KFU: |
